Ultron Pharma India Private Limited - Company Profile

It is a chemicals private limited company based in Bhopal, Madhya Pradesh, India, established in 2015.
2015 Bhopal, Madhya Pradesh, India Struck Off
Last Updated:
Access Report
About Ultron Pharma India Private Limited

Ultron Pharma India Private Limited, a struck off private limited company, was established on 13 February 2015 in Bhopal, Madhya Pradesh, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U24230MP2015PTC033837. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Rehana Khan (Director), Farhat Hameed Khan (Director). Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at 13/14 Housing Board Colony Koh-E-Fiza, Bhopal, Madhya Pradesh, 462001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MP2015PTC033837

  • Registration Number

    033837

  • Incorporation Date

    13 February 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 15 Days
  • Last Filing with ROC 31 Mar 2017
Company report

Ultron Pharma India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ultron Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ultron Pharma India Private Limited?
Current Directors
Name Designation Appointment Date Status
Rehana Khan Director 13 Feb 2015 Current
Farhat Hameed Khan Director 13 Feb 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ultron Pharma India.

Ultron Pharma India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Ultron Pharma India revenue growth over time
Ultron Pharma India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ultron Pharma India?

In 2017, Ultron Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ultron Pharma India?

Unlock and access historical data on people associated with Ultron Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ultron Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultron Pharma India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ultron Pharma India
Recent Activity within the Organization
  • Annual General Meeting

    The activity Ultron Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Ultron Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Gwalior. was documented.

  • Director Appointment

    Rehana Khan was appointed as a Director was appointed as a Director on 13 Feb 2015 & has been associated with this company since 11 years 15 days . was recorded as a recent event.

  • Director Appointment

    The activity Farhat Hameed Khan was appointed as a Director was appointed as a Director on 13 Feb 2015 & has been associated with this company since 11 years 15 days . was completed.

  • Company Incorporation

    The activity Ultron Pharma India Private Limited was registered on 13 Feb 2015 with Roc Gwalior & aged 11 years 15 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ultron Pharma India Private Limited?

The CIN of Ultron Pharma India Private Limited is U24230MP2015PTC033837.

Where is Ultron Pharma India Private Limited headquartered?

Ultron Pharma India Private Limited is headquartered at 13/14 Housing Board Colony Koh-E-Fiza, Bhopal, Madhya Pradesh, 462001.

When was Ultron Pharma India Private Limited incorporated?

Ultron Pharma India Private Limited was incorporated on 13 February 2015.

Who are the current directors of Ultron Pharma India Private Limited?

The current directors of Ultron Pharma India Private Limited are

What is the primary industry of Ultron Pharma India Private Limited?

The primary industry of Ultron Pharma India Private Limited is Manufacturing.

Is Ultron Pharma India Private Limited a listed company?

Ultron Pharma India Private Limited is unlisted.

What is the capital structure of Ultron Pharma India Private Limited?

The authorized capital of Ultron Pharma India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available